Results 31 to 40 of about 143,948 (293)

Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review

Gerontology, 2019
Benign prostatic hyperplasia (BPH), benign prostatic enlargement (BPE) and lower urinary tract symptoms (LUTS) belong to the most frequent diseases in ageing men.
S. Madersbacher, N. Sampson, Z. Culig
semanticscholar   +1 more source

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes

Nature Communications, 2020
Benign prostatic hyperplasia (BPH), a nonmalignant enlargement of the prostate, is among the most common diseases affecting aging men, but the underlying molecular features remain poorly understood, and therapeutic options are limited.
Deli Liu, J. Shoag, D. Poliak, R. Goueli, Vaishali Ravikumar, D. Redmond, A. Vosoughi, J. Fontugne, H. Pan, Daniel J. Lee, Domonique Thomas, K. Salari, Zongwei Wang, A. Romanel, A. Te, R. Lee, B. Chughtai, A. Olumi, J. Mosquera, F. Demichelis, O. Elemento, M. Rubin, A. Sboner, C. Barbieri   +23 more
semanticscholar   +1 more source

Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study

Military Medical Research, 2019
Background Both periodontal disease and benign prostatic hyperplasia are age-related diseases that affect millions of people worldwide. Hence, this study aimed to investigate the association between periodontal disease and the risk of benign prostatic ...
Lan Wu, Bing-Hui Li, Yun-Yun Wang, Chao-Yang Wang, Hao Zi, Hong Weng, Qiao Huang, You-Jia Zhu, Xian-Tao Zeng   +8 more
doaj   +1 more source

Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial

British medical journal, 2018
Objective To compare prostatic artery embolisation (PAE) with transurethral resection of the prostate (TURP) in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia in terms of patient reported and functional outcomes ...
D. Abt, L. Hechelhammer, G. Müllhaupt, S. Markart, S. Güsewell, T. Kessler, H. Schmid, D. Engeler, L. Mordasini   +8 more
semanticscholar   +1 more source

Benign prostatic hyperplasia

Nature Reviews Disease Primers, 2022
B. Chughtai, J. Forde, Dominique Thomas, Leanna Laor, T. Hossack, H. Woo, A. Te, S. Kaplan   +7 more
semanticscholar   +4 more sources

Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples [PDF]

, 2013
Emerging evidence has shown that the tumor microenvironment plays a crucial role in prostate cancer (PCa) development and progression. However, the mechanism(s) through which stromal cells regulate epithelial cells and the differences among prostatic ...
Clemente, Luigi Di, Festuccia, Claudio, Gravina, Giovanni Luca, Mancini, Andrea, Marampon, Francesco, Pasquale, Boris Di, Ranieri, Guido, Ricevuto, Enrico   +7 more
core   +1 more source

Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.

Translational Andrology and Urology, 2019
Benign prostatic hyperplasia (BPH) is one of the most common conditions affecting men. BPH can lead to a number of symptoms for patients commonly referred to as lower urinary tract symptoms (LUTS). Over the last decade, increased modifiable risk factors,
S. Lokeshwar, Benjamin T. Harper, E. Webb, Andre R. Jordan, T. Dykes, D. Neal, M. Terris, Z. Klaassen   +7 more
semanticscholar   +1 more source

Empowering patient choice: a systematic review of decision aids for benign prostatic hyperplasia. [PDF]

BJU Int
Background Benign prostatic hyperplasia (BPH) is a complex condition that affects ~3.2 million men in the UK. As men often face multiple treatment options, discussion and consideration of their priorities and preferences is necessary; however, research indicates this is not always adopted in practice.
Hollands C, Gray D, Marren A, Hindley R, Husted M.   +4 more
europepmc   +2 more sources

Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera. [PDF]

, 2018
Currently prostate-specific antigen is used for prostate cancer (PCa) screening, however it lacks the necessary specificity for differentiating PCa from other diseases of the prostate such as benign prostatic hyperplasia (BPH), presenting a clinical need
Adusumilli, Ravali, Brooks, James D, Kullolli, Majlinda, Mallick, Parag, Pitteri, Sharon J, Tanimoto, Cheylene, Totten, Sarah M   +6 more
core   +2 more sources

Clinicopathological Study of Prostatic Biopsies [PDF]

Journal of Clinical and Diagnostic Research, 2014
Introduction: Prostatism is a common malady in the geriatric age group. Benign prostatic hyperplasia and Carcinoma of the prostate are increasingly frequent with advancing age. The aim of the present study is to study the spectrum of prostatic lesions
A.JOSEPHINE
doaj   +1 more source